Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1306.439
- +4.687+0.36%
10 Health Care Stocks With Whale Alerts In Today's Session
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Peering Into Intellia Therapeutics's Recent Short Interest
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $500
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Vertex Announces U.S. FDA Approval For TRIKAFTA To Include Additional Non-F508del TRIKAFTA-Responsive Variants
UBS Says 'Underweight the Names With High China Exposure'
J.P. Morgan's Top Healthcare Stocks for 2025
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
JMP Securities Reiterates Market Outperform on CRISPR Therapeutics, Maintains $86 Price Target
CRISPR Therapeutics Analyst Ratings
Needham Reiterates Hold on Vertex Pharmaceuticalsto Hold
The Dow barely ended its longest continuous decline in 50 years, Micron fell by 16%, the US dollar reached a two-year high again, and US bonds, oil, and Bitcoin all dropped.
U.S. stock market's other Indexes turned down towards the end, Tesla rose by nearly 4% before closing down, NVIDIA reached a high of 4%, and Micron Technology had its steepest decline in five years. The yield on the 10-year U.S. Treasury bonds briefly increased by nearly 10 basis points approaching 4.60%, close to a seven-month high, while short-term bond yields fell, with the 2/10-year yield spread at its widest in two and a half years. The Bank of England held rates steady, but more officials supported a rate cut, leading to a decline in the British Pound. The Governor of the Bank of Japan suppressed interest rate hike expectations, causing the yen to fall towards 158, and the offshore renminbi briefly dropped below 7.32 yuan to its lowest in 15 months. Bitcoin fell by 5%, approaching $0.096 million. Spot Gold rose by 1.6% before narrowing back below $2,600, while the futures silver fell by 5%, and U.S. crude oil fell below $70.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Vertex Downgraded to Perform by Oppenheimer
Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?